Obi-Wan finale + Healthcare’s hidden money pit with Capital RX CEO AJ Loiacono | E1491

This Week in Startups

Jason Calacanis

Technology

4.4 • 1.3K Ratings

🗓️ 23 June 2022

⏱️ 101 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

Today we bring on Lon Harris to discuss the Obi-Wan Kenobi finale (2:23), then we do a quick hit on the FDA taking action against Juul (42:14). Finally, Molly chats with AJ Loiacono from Capital RX, who is laser-focused on increasing transparency in prescription drug pricing (55:26).

(0:00) Jason and Molly intro today’s show
(2:23) Lon Harris joins to recap the Obi-Wan Kenobi finale
(10:45) BairesDev - Go to https://www.baires.dev/twist and get $10k off when you sign your first contract
(11:58) Favorite scenes from the Obi-Wan finale
(27:21) Thorne - Personalized, scientific wellness. Go to https://Thorne.com/u/TWIST
(28:35) Thoughts on the Obi-Wan series and finale, will they make live-action clone wars?
(34:50) AdQuick - Visit https://adquick.com/twist and mention TWIST to get $1000 off your first campaign.
(36:07) Discussing the franchise value of Star Wars
(39:56) Jason’s previous Obi-Wan prediction
(42:14) FDA is banning the sale of Juuls in the US (other e-cigarettes will still be available though)
(54:05) Toss to Molly’s interview with AJ Loiacono
(55:26) AJ Loiacono, CEO of Capital RX, who is laser-focused on increasing transparency in prescription drug pricing
(1:40:14) Outro: coming up later this week

Transcript

Click on a timestamp to play from that location

0:00.0	Hey, everybody. We have got a packed Thursday show for you today. It's a short week. So we
0:05.0	have to give you like a double link through. All right. Yes. The OB-1 series finale is
0:11.8	tremendous. And we're going to talk about it all. You can skip ahead if you haven't seen
0:14.9	the finale yet and go to the other great content in the episode. But Lon Harris is back with us
0:19.0	to discuss. Yeah. What this means for streaming and the episode itself, very satisfying for me.
0:24.3	Very satisfying conversation. And again, there's still lots of other content coming up. We're
0:28.4	going to do a quick news hit on the FDA taking action against Jewel. And then I've got an interview
0:34.0	with a series C healthcare CEO. They say it can't be done. But he's trying to disrupt drug prices.
0:41.1	Yes. This is AJ from CapitalRX. Laser focused on transparency and prescription drug pricing.
0:46.5	Like the Mark Cuban company, which we'll also have on the show at some point. And just, you know,
0:50.0	great to see founders doing the right thing, especially with this news of Jewel, which did the
0:54.8	wrong thing for a decade. Definitely. We're really, it's really interesting because we have that
0:59.2	news. And then a CEO who quite specifically is saying, I'm not taking the dirty money.
1:02.9	There you go. That's the money we're never going to take. It's going to be a great show.
1:05.9	All right. Stick with us. This week in startups is brought to you by
1:10.5	Byrace Dev. Hiring a team of experienced developers doesn't need to be hard, slow,
1:16.5	expensive, or risky. Go to Byrace.dev slash twist and schedule a 20 minute chat to get a
1:23.9	development team. You'll love and get $10,000 off when you sign your first contract.
1:30.0	Thorn Thorn empowers people to take control of their long-term well-being
1:35.1	with the proactive science-based approach to health. Through a variety of at-home tests,
1:40.6	Thorn teaches you about what your body needs and provides the right high-quality,
1:45.5	certified nutritional supplements for you. To get started and take 10% off your first order,
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from Jason Calacanis, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Jason Calacanis and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.